PPMS Studies Update: New Research on PPMS and Multiple Sclerosis
MS research is evolving rapidly – and for people living with PPMS, SPMS, or relapsing-remitting MS, staying up to date can make a real difference.
On this page you’ll find current scientific MS and PPMS studies: new therapeutic approaches, insights into remyelination, immunotherapies, and much more.
The studies featured on this page are drawn from the continuously updated collection at brain-regeneration.com, powered by Gregory MS, an AI Tool developed by Bruno Amaral, who lives with progressive MS himself. You can also sign up there directly for alerts on new clinical trials.
The original articles are written in English and are deliberately left untranslated: with medical terminology, translation can easily introduce inaccuracies that distort the medical reality. If you have questions about a specific study, please discuss them with your doctor.
What is the world currently researching about Multiple Sclerosis?
The answer is more encouraging than many would expect. For a long time, PPMS was considered a therapeutic dead end – too few relapses to justify classic immunotherapies, too complex to address with single agents. But the picture has changed. Researchers worldwide are working on new approaches: on remyelination, meaning the rebuilding of destroyed myelin sheaths; on controlling the silent inflammation that contributes to progression even without visible relapses; and on deep immunotherapies that fundamentally recalibrate the misdirected immune system.
This page brings together current study results from international medical journals – continuously updated, so you stay informed and can have conversations with your doctors on equal footing. Because knowledge changes how one deals with a diagnosis: it doesn’t turn patients into experts – but it gives them the tools to ask the right questions.
Latest PPMS Studies and Research Findings
Ungültige API-Antwort.
